A single blood test that screens for eight common cancer types and helps identify the location of the cancer has been developed at the Johns Hopkins Kimmel Cancer Center. The test, called CancerSEEK, is a unique noninvasive, multianalyte test that simultaneously evaluates levels of eight cancer proteins and the presence of cancer gene mutations from circulating DNA in the blood. The test is aimed at screening for eight common cancer types that account for more than 60 percent of cancer deaths in the U.S. Five of the cancers covered by the test currently have no screening test.
Cross-dressing dendritic cells, in other words, making them acquire and present tumor antigens on their surface could make immunotherapy for solid tumors more effective, according to a group of scientists at École Polytechnique Fédérale de Lausanne (EPFL).
Drugs that boost the immune system have revolutionized immunotherapy for certain cancers. However, only 35 percent of patients with melanoma benefit from such drugs. Specific strains of bacteria that naturally dwell in the intestines can improve the response to immunotherapy for patients being treated for advanced melanoma, finds a study conducted by a research team at the University of Chicago Medicine.